[1] 邵志敏,沈镇宙,郭小毛.肿瘤医学(上册)[M].上海:复旦大学出版社,2019:3-22.
[2] Sung H, Ferlay J, Siegel RL,et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021,71(3):209-249.DOI: 10.3322/caac.21660.
[3] Almagro J, Messal HA, Elosegui-Artola A,et al. Tissue architecture in tumor initiation and progression[J]. Trends Cancer, 2022,8(6):494-505. DOI: 10.1016/j.trecan.2022.02.007.
[4] Yuan S, Almagro J, Fuchs E. Beyond genetics: driving cancer with the tumour microenvironment behind the wheel[J]. Nat Rev Cancer, 2024,24(4):274-286.DOI: 10.1038/s41568-023-00660-9.
[5] de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth[J]. Cancer Cell, 2023,41(3):374-403.DOI: 10.1016/j.ccell.2023.02.016.
[6] Rozenblatt-Rosen O, Regev A, Oberdoerffer P,et al. The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution[J]. Cell, 2020,181(2):236-249.DOI: 10.1016/j.cell.2020.03.053.
[7] Liu H, Dong Z. Cancer etiology and prevention principle: "1 + X"[J]. Cancer Res, 2021 ,81(21):5377-5395.DOI: 10.1158/0008-5472.CAN-21-1862.
[8] Islami F, Siegel RL, Jemal A. The changing landscape of cancer in the USA - opportunities for advancing prevention and treatment[J]. Nat Rev Clin Oncol, 2020,17(10):631-649. DOI: 10.1038/s41571-020-0378-y.
[9] Mao JJ, Pillai GG, Andrade CJ,et al. Integrative oncology: addressing the global challenges of cancer prevention and treatment[J]. CA Cancer J Clin, 2022,72(2):144-164. DOI: 10.3322/caac.21706.
[10] Laplane L, Duluc D, Larmonier N,et al. The multiple layers of the tumor environment[J]. Trends Cancer, 2018,4(12):802-809. DOI: 10.1016/j.trecan.2018.10.002.
[11] Chen X, Song E. The theory of tumor ecosystem[J]. Cancer Commun (Lond), 2022,42(7):587-608. DOI: 10.1002/cac2.12316.
[12] Schneider G, Schmidt-Supprian M, Rad R,et al. Tissue-specific tumorigenesis: context matters[J]. Nat Rev Cancer, 2017,17(4):239-253. DOI: 10.1038/nrc.2017.5.
[13] 赵平,王陇德,黎钧耀.预防肿瘤学[M].北京:人民卫生出版社,2015:291-560.
[14] Weeden CE, Hill W, Lim EL,et al. Impact of risk factors on early cancer evolution[J]. Cell, 2023,186(8):1541-1563.DOI: 10.1016/j.cell.2023.03.013.
[15] Wong KCW, Hui EP, Lo KW,et al. Nasopharyngeal carcinoma: an evolving paradigm[J]. Nat Rev Clin Oncol, 2021,18(11):679-695.DOI: 10.1038/s41571-021- 00524-x.
[16] Chen YP, Chan ATC, Le QT,et al. Nasopharyngeal carcinoma[J]. Lancet, 2019,394(10192):64-80.DOI: 10.1016/S0140-6736(19)30956-0.
[17] Su ZY, Siak PY, Lwin YY, et al. Epidemiology of nasopharyngeal carcinoma: current insights and future outlook[J]. Cancer Metastasis Rev,2024,43(3):919-939.DOI: 10.1007/s10555-024-10176-9.
[18] Huang T, Ploner A, Chang ET,et al. Dietary patterns and risk of nasopharyngeal carcinoma: a population-based case-control study in southern China[J]. Am J Clin Nutr, 2021,114(2):462-471.DOI: 10.1093/ajcn/nqab114.
[19] Chen L, Zhang M, Zhou J,et al. Establishment of an age- and tumor microenvironment-related gene signature for survival prediction in prostate cancer[J]. Cancer Med, 2022,11(22):4374-4388.DOI: 10.1002/cam4.4776.
|